National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
R37AI150560
米国
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
R01AI176904
米国
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
P01AI150471
米国
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
F31AI176650
米国
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
T32 AI055403
米国
引用
ジャーナル: bioRxiv / 年: 2024 タイトル: The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC. 著者: Jonathan Richard / Michael W Grunst / Ling Niu / Marco A Díaz-Salinas / William D Tolbert / Lorie Marchitto / Fei Zhou / Catherine Bourassa / Derek Yang / Ta Jung Chiu / Hung-Ching Chen / ...著者: Jonathan Richard / Michael W Grunst / Ling Niu / Marco A Díaz-Salinas / William D Tolbert / Lorie Marchitto / Fei Zhou / Catherine Bourassa / Derek Yang / Ta Jung Chiu / Hung-Ching Chen / Mehdi Benlarbi / / Suneetha Gottumukkala / Wenwei Li / Katrina Dionne / Étienne Bélanger / Debashree Chatterjee / Halima Medjahed / Wayne A Hendrickson / Joseph Sodroski / Zabrina C Lang / Abraham J Morton / Rick K Huang / Doreen Matthies / Amos B Smith / Walther Mothes / James B Munro / Marzena Pazgier / Andrés Finzi / 要旨: HIV-1 envelope glycoproteins (Env) from primary HIV-1 isolates typically adopt a pretriggered "closed" conformation that resists to CD4-induced (CD4i) non-neutralizing antibodies (nnAbs) mediating ...HIV-1 envelope glycoproteins (Env) from primary HIV-1 isolates typically adopt a pretriggered "closed" conformation that resists to CD4-induced (CD4i) non-neutralizing antibodies (nnAbs) mediating antibody-dependent cellular cytotoxicity (ADCC). CD4-mimetic compounds (CD4mcs) "open-up" Env allowing binding of CD4i nnAbs, thereby sensitizing HIV-1-infected cells to ADCC. Two families of CD4i nnAbs, the anti-cluster A and anti-coreceptor binding site (CoRBS) Abs, are required to mediate ADCC in combination with the indane CD4mc BNM-III-170. Recently, new indoline CD4mcs with improved potency and breadth have been described. Here, we show that the lead indoline CD4mc, CJF-III-288, sensitizes HIV-1-infected cells to ADCC mediated by anti-CoRBS Abs alone, contributing to improved ADCC activity. Structural and conformational analyses reveal that CJF-III-288, in combination with anti-CoRBS Abs, potently stabilizes an asymmetric "open" State-3 Env conformation, This Env conformation orients the anti-CoRBS Ab to improve ADCC activity and therapeutic potential.